SCHEMBL793905

SCHEMBL793905

C#C/[C]=C/C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20138601 0.64
SCHEMBL5991803 0.62
SCHEMBL3596753 0.57
SCHEMBL169861 0.56
Butadiene SCHEMBL11812706 0.56
Butadiene SCHEMBL10934316 0.56
SCHEMBL4665561 0.56
SCHEMBL7055034 0.54
SCHEMBL187115 0.54
SCHEMBL1788406 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515923-A1 PRODRUGS OF FLUORINATED ACYCLIC NUCLEOSIDE PHOSPHONATES Katholieke Universiteit Leuven (BE) 2019-07-31 EP disclosed
WO-2018134399-A1 NOVEL PRODRUGS OF MIZORIBINE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2018-07-26 WO disclosed
WO-2018055071-A1 PRODRUGS OF FLUORINATED ACYCLIC NUCLEOSIDE PHOSPHONATES KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2018-03-29 WO disclosed
EP-3016958-A1 NOVEL GAK MODULATORS Katholieke Universiteit Leuven (BE) 2016-05-11 EP disclosed
WO-2016012536-A1 GAK MODULATORS AS ANTIVIRALS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-01-28 WO disclosed
EP-2864312-A2 NOVEL ANTI-CANCER COMPOUNDS Katholieke Universiteit Leuven (BE) 2015-04-29 EP disclosed
WO-2015001076-A1 NOVEL GAK MODULATORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2015-01-08 WO disclosed
WO-2013190137-A2 NOVEL ANTI-CANCER COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2013-12-27 WO disclosed
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
EP-2575969-A1 ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-04-10 EP disclosed
WO-2007022945-A2 MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS VIACATT N.V. (BE) 2007-03-01 WO disclosed
EP-1742920-A2 NAPHTHALIMIDE DERIVATIVES FOR THE TREATMENT OF CANCER Unibioscreen S.A. (BE) 2007-01-17 EP disclosed
WO-2006069805-A2 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT 4 AZA IP NV (BE) 2006-07-06 WO disclosed
EP-1673092-A1 HETEROCYCLE-SUBSTITUTED PTERIDINE DERIVATIVES AND THEIR USE IN THERAPY 4 AZA Bioscience nv (BE) 2006-06-28 EP disclosed
WO-2006060884-A1 7-(2-CYCLOHEXYLIDENE-ETHYLIDENE)-SPIRO[4.5]DECANES K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2006-06-15 WO disclosed
WO-2006005142-A2 MONO- AND POLYCYCLIC COMPOUNDS WITH THERAPEUTIC ACTIVITY, PHARMACEUTICAL COMPOSITIONS INCLUDING THEM AND INTERMEDIATES FOR MAKING THEM UNIVERSITEIT GENT (BE) 2006-01-19 WO disclosed
WO-2005105753-A2 NAPHTHALIMIDE DERIVATIVES, METHODS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THEREFROM UNIBIOSCREEN S.A. (BE) 2005-11-10 WO disclosed
WO-2005082819-A2 METAL COMPLEXES FOR USE IN OLEFIN METATHESIS AND ATOM GROUP TRANSFER REACTIONS UNIVERSITEIT GENT (BE) 2005-09-09 WO disclosed
WO-2005039587-A1 HETEROCYCLE-SUBSTITUTED PTERIDINE DERIVATIVES AND THEIR USE IN THERAPY 4 AZA BIOSCIENCE NV (BE) 2005-05-06 WO disclosed
WO-2005035121-A2 SCHIFF BASE METAL COMPLEXES FOR USE AS CATALYSTS IN ORGANIC SYNTHESIS UNIVERSITEIT GENT (BE) 2005-04-21 WO disclosed